[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f26Y6_yves8-sHUWTCiiKjJ7cSOCpoaPk02AlA5B1CWc":3},{"article":4,"iocs":44},{"id":5,"title":6,"slug":7,"summary":8,"ai_summary":9,"brief":10,"full_text":11,"url":12,"image_url":13,"published_at":14,"ingested_at":15,"relevance_score":16,"entities":17,"category_id":27,"category":28,"article_tags":31},"285d1c4b-6b88-45d8-baac-76081c6b1836","Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT","apollo-pharmacy-blood-glucose-monitoring-system-apg-01-bt-7d77cc","View CSAF Summary Successful exploitation of these vulnerabilities could allow an attacker to obtain sensitive health-related information and prevent legitimate users from establishing a connection with the device. The following versions of Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT are affected: Blood Glucose Monitoring System (Model No. APG-01 BT) 0x0110_v1.1.0 (CVE-2026-50034, CVE-2026-52866) CVSS Vendor Equipment Vulnerabilities v3 6.5 Apollo Pharmacy Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Cleartext Transmission of Sensitive Information, Missing Authorization Background Critical Infrastructure Sectors: Healthcare and Public Health Countries\u002FAreas Deployed: India Company Headquarters Location: India Vulnerabilities Expand All + CVE-2026-50034 An attacker within BLE communication range can passively intercept wireless traffic and obtain sensitive health-related information, including glucose measurement values. View CVE Details Affected Products Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Vendor: Apollo Pharmacy Product Version: Apollo Pharmacy Blood Glucose Monitoring System (Model No. APG-01 BT): 0x0110_v1.1.0 Product Status: known_affected Remediations Mitigation Apollo Pharmacy did not respond to CISA's requests to coordinate. Users are encouraged to reach out to Apollo Pharmacy directly for more information:https:\u002F\u002Fwww.apollopharmacy.in\u002Fcontact-us. https:\u002F\u002Fwww.apollopharmacy.in\u002Fcontact-us Mitigation CISA recommends users follow the guidance in the Understanding Bluetooth Technology blog https:\u002F\u002Fwww.cisa.gov\u002Fnews-events\u002Fnews\u002Funderstanding-bluetooth-technology. https:\u002F\u002Fwww.cisa.gov\u002Fnews-events\u002Fnews\u002Funderstanding-bluetooth-technology Relevant CWE: CWE-319 Cleartext Transmission of Sensitive Information Metrics CVSS Version Base Score Base Severity Vector String 3.1 6.5 MEDIUM CVSS:3.1\u002FAV:A\u002FAC:L\u002FPR:N\u002FUI:N\u002FS:U\u002FC:H\u002FI:N\u002FA:N 4.0 7.1 HIGH CVSS:4.0\u002FAV:A\u002FAC:L\u002FAT:N\u002FPR:N\u002FUI:N\u002FVC:H\u002FVI:N\u002FVA:N\u002FSC:N\u002FSI:N\u002FSA:N CVE-2026-52866 An attacker within BLE communication range can monopolize the device's only available BLE connection slot, preventing legitimate users or applications from establishing a connection. View CVE Details Affected Products Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Vendor: Apollo Pharmacy Product Version: Apollo Pharmacy Blood Glucose Monitoring System (Model No. APG-01 BT): 0x0110_v1.1.0 Product Status: known_affected Remediations Mitigation Apollo Pharmacy did not respond to CISA's requests to coordinate. Users are encouraged to reach out to Apollo Pharmacy directly for more information:https:\u002F\u002Fwww.apollopharmacy.in\u002Fcontact-us. https:\u002F\u002Fwww.apollopharmacy.in\u002Fcontact-us Mitigation CISA recommends users follow the guidance in the Understanding Bluetooth Technology blog https:\u002F\u002Fwww.cisa.gov\u002Fnews-events\u002Fnews\u002Funderstanding-bluetooth-technology. https:\u002F\u002Fwww.cisa.gov\u002Fnews-events\u002Fnews\u002Funderstanding-bluetooth-technology Relevant CWE: CWE-862 Missing Authorization Metrics CVSS Version Base Score Base Severity Vector String 3.1 6.5 MEDIUM CVSS:3.1\u002FAV:A\u002FAC:L\u002FPR:N\u002FUI:N\u002FS:U\u002FC:N\u002FI:N\u002FA:H 4.0 7.1 HIGH CVSS:4.0\u002FAV:A\u002FAC:L\u002FAT:N\u002FPR:N\u002FUI:N\u002FVC:N\u002FVI:N\u002FVA:H\u002FSC:N\u002FSI:N\u002FSA:N Acknowledgments Rishitha Pucchakayala and Centre for Development of Advanced Computing (Hyderabad) reported these vulnerabilities to CISA Legal Notice and Terms of Use This product is provided subject to this Notification (https:\u002F\u002Fwww.cisa.gov\u002Fnotification) and this Privacy & Use policy (https:\u002F\u002Fwww.cisa.gov\u002Fprivacy-policy). Recommended Practices CISA recommends users take defensive measures to minimize the risk of exploitation of these vulnerabilities. Minimize network exposure for all control system devices and\u002For systems, ensuring they are not accessible from the internet. Locate control system networks and remote devices behind firewalls and isolating them from business networks. When remote access is required, use more secure methods, such as Virtual Private Networks (VPNs), recognizing VPNs may have vulnerabilities and should be updated to the most current version available. Also recognize VPN is only as secure as the connected devices. CISA reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures. CISA also provides a section for control systems security recommended practices on the ICS webpage on cisa.gov\u002Fics. Several CISA products detailing cyber defense best practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies. CISA encourages organizations to implement recommended cybersecurity strategies for proactive defense of ICS assets. Additional mitigation guidance and recommended practices are publicly available on the ICS webpage at cisa.gov\u002Fics in the technical information paper, ICS-TIP-12-146-01B--Targeted Cyber Intrusion Detection and Mitigation Strategies. Organizations observing suspected malicious activity should follow established internal procedures and report findings to CISA for tracking and correlation against other incidents. No known public exploitation specifically targeting these vulnerabilities has been reported to CISA at this time. These vulnerabilities are not exploitable remotely. Revision History Initial Release Date: 2026-06-18 Date Revision Summary 2026-06-18 1 Initial Publication Legal Notice and Terms of Use","Two vulnerabilities have been identified in the Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT (Model No. APG-01 BT, version 0x0110_v1.1.0). CVE-2026-50034 allows attackers within Bluetooth Low Energy (BLE) range to intercept sensitive health data, while CVE-2026-52866 enables them to monopolize the device's connection slot, preventing legitimate users from connecting. Apollo Pharmacy has not responded to CISA's requests for coordination.","Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT has two vulnerabilities allowing data interception and","ICS Medical Advisory Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Release DateJune 18, 2026 Alert CodeICSMA-26-169-01 Related topics: Industrial Control System Vulnerabilities , Industrial Control Systems View CSAF Summary Successful exploitation of these vulnerabilities could allow an attacker to obtain sensitive health-related information and prevent legitimate users from establishing a connection with the device. The following versions of Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT are affected: Blood Glucose Monitoring System (Model No. APG-01 BT) 0x0110_v1.1.0 (CVE-2026-50034, CVE-2026-52866) CVSS Vendor Equipment Vulnerabilities v3 6.5 Apollo Pharmacy Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Cleartext Transmission of Sensitive Information, Missing Authorization Background Critical Infrastructure Sectors: Healthcare and Public Health Countries\u002FAreas Deployed: India Company Headquarters Location: India Vulnerabilities Expand All + CVE-2026-50034 An attacker within BLE communication range can passively intercept wireless traffic and obtain sensitive health-related information, including glucose measurement values. View CVE Details Affected Products Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Vendor:Apollo Pharmacy Product Version:Apollo Pharmacy Blood Glucose Monitoring System (Model No. APG-01 BT): 0x0110_v1.1.0 Product Status:known_affected Remediations MitigationApollo Pharmacy did not respond to CISA's requests to coordinate. Users are encouraged to reach out to Apollo Pharmacy directly for more information:https:\u002F\u002Fwww.apollopharmacy.in\u002Fcontact-us.https:\u002F\u002Fwww.apollopharmacy.in\u002Fcontact-us MitigationCISA recommends users follow the guidance in the Understanding Bluetooth Technology blog https:\u002F\u002Fwww.cisa.gov\u002Fnews-events\u002Fnews\u002Funderstanding-bluetooth-technology.https:\u002F\u002Fwww.cisa.gov\u002Fnews-events\u002Fnews\u002Funderstanding-bluetooth-technology Relevant CWE: CWE-319 Cleartext Transmission of Sensitive Information Metrics CVSS Version Base Score Base Severity Vector String 3.1 6.5 MEDIUM CVSS:3.1\u002FAV:A\u002FAC:L\u002FPR:N\u002FUI:N\u002FS:U\u002FC:H\u002FI:N\u002FA:N 4.0 7.1 HIGH CVSS:4.0\u002FAV:A\u002FAC:L\u002FAT:N\u002FPR:N\u002FUI:N\u002FVC:H\u002FVI:N\u002FVA:N\u002FSC:N\u002FSI:N\u002FSA:N CVE-2026-52866 An attacker within BLE communication range can monopolize the device's only available BLE connection slot, preventing legitimate users or applications from establishing a connection. View CVE Details Affected Products Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Vendor:Apollo Pharmacy Product Version:Apollo Pharmacy Blood Glucose Monitoring System (Model No. APG-01 BT): 0x0110_v1.1.0 Product Status:known_affected Remediations MitigationApollo Pharmacy did not respond to CISA's requests to coordinate. Users are encouraged to reach out to Apollo Pharmacy directly for more information:https:\u002F\u002Fwww.apollopharmacy.in\u002Fcontact-us.https:\u002F\u002Fwww.apollopharmacy.in\u002Fcontact-us MitigationCISA recommends users follow the guidance in the Understanding Bluetooth Technology blog https:\u002F\u002Fwww.cisa.gov\u002Fnews-events\u002Fnews\u002Funderstanding-bluetooth-technology.https:\u002F\u002Fwww.cisa.gov\u002Fnews-events\u002Fnews\u002Funderstanding-bluetooth-technology Relevant CWE: CWE-862 Missing Authorization Metrics CVSS Version Base Score Base Severity Vector String 3.1 6.5 MEDIUM CVSS:3.1\u002FAV:A\u002FAC:L\u002FPR:N\u002FUI:N\u002FS:U\u002FC:N\u002FI:N\u002FA:H 4.0 7.1 HIGH CVSS:4.0\u002FAV:A\u002FAC:L\u002FAT:N\u002FPR:N\u002FUI:N\u002FVC:N\u002FVI:N\u002FVA:H\u002FSC:N\u002FSI:N\u002FSA:N Acknowledgments Rishitha Pucchakayala and Centre for Development of Advanced Computing (Hyderabad) reported these vulnerabilities to CISA Legal Notice and Terms of Use This product is provided subject to this Notification (https:\u002F\u002Fwww.cisa.gov\u002Fnotification) and this Privacy & Use policy (https:\u002F\u002Fwww.cisa.gov\u002Fprivacy-policy). Recommended Practices CISA recommends users take defensive measures to minimize the risk of exploitation of these vulnerabilities. Minimize network exposure for all control system devices and\u002For systems, ensuring they are not accessible from the internet. Locate control system networks and remote devices behind firewalls and isolating them from business networks. When remote access is required, use more secure methods, such as Virtual Private Networks (VPNs), recognizing VPNs may have vulnerabilities and should be updated to the most current version available. Also recognize VPN is only as secure as the connected devices. CISA reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures. CISA also provides a section for control systems security recommended practices on the ICS webpage on cisa.gov\u002Fics. Several CISA products detailing cyber defense best practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies. CISA encourages organizations to implement recommended cybersecurity strategies for proactive defense of ICS assets. Additional mitigation guidance and recommended practices are publicly available on the ICS webpage at cisa.gov\u002Fics in the technical information paper, ICS-TIP-12-146-01B--Targeted Cyber Intrusion Detection and Mitigation Strategies. Organizations observing suspected malicious activity should follow established internal procedures and report findings to CISA for tracking and correlation against other incidents. No known public exploitation specifically targeting these vulnerabilities has been reported to CISA at this time. These vulnerabilities are not exploitable remotely. Revision History Initial Release Date: 2026-06-18 Date Revision Summary 2026-06-18 1 Initial Publication Legal Notice and Terms of Use This product is provided subject to this Notification and this Privacy & Use policy. Tags Sector: Healthcare and Public Health Sector Topics: Industrial Control System Vulnerabilities, Industrial Control Systems Please share your thoughts We recently updated our anonymous product survey; we welcome your feedback. Related Advisories May 28, 2026 ICS Medical Advisory | ICSMA-26-148-01 Fourth Frontier Frontier X Mobile Application, Frontier X2 May 26, 2026 ICS Medical Advisory | ICSMA-26-146-01 Eppendorf BioFlo 320 Mar 24, 2026 ICS Medical Advisory | ICSMA-26-083-01 Grassroots DICOM (GDCM) Feb 10, 2026 ICS Medical Advisory | ICSMA-26-041-01 ZOLL ePCR IOS Mobile Application","https:\u002F\u002Fwww.cisa.gov\u002Fnews-events\u002Fics-medical-advisories\u002Ficsma-26-169-01",null,"2026-06-18T12:00:00+00:00","2026-06-18T18:00:17.748291+00:00",8,[18,21,24],{"name":19,"type":20},"Blood Glucose Monitoring System APG-01 BT","product",{"name":22,"type":23},"Apollo Pharmacy","vendor",{"name":25,"type":26},"Bluetooth Low Energy","technology","80544778-fabb-4dcd-aa35-17492e5dcf4f",{"id":27,"icon":13,"name":29,"slug":30},"Vulnerabilities","vulnerabilities",[32,37,39],{"category":33},{"id":34,"icon":13,"name":35,"slug":36},"614132b8-5837-4952-b8b5-c6c9a32a1d85","Privacy","privacy",{"category":38},{"id":27,"icon":13,"name":29,"slug":30},{"category":40},{"id":41,"icon":13,"name":42,"slug":43},"d6f63bb8-0801-486a-be7f-171400700454","IoT\u002FOT","iot-ot",[45,49],{"type":46,"value":47,"context":48},"cve","CVE-2026-50034","Cleartext transmission of sensitive health information via BLE.",{"type":46,"value":50,"context":51},"CVE-2026-52866","Denial of service by monopolizing BLE connection slot."]